HOME >> MEDICINE >> NEWS
Pregnancy, not high-risk behavior, predictor of STD testing among newly homeless youth

In the first study of its kind focusing on newly homeless youth, UCLA researchers have found that high-risk sexual behavior did not predict whether these youths were tested for sexually transmitted diseases. Instead, they were tested only when someone became pregnant or got someone pregnant.

The findings, to be published in the May issue of the peer-reviewed journal AIDS and Behavior and available online at http://dx.doi.org/10.1007/s10461-005-9044-8, indicate that there is an urgent need for outreach programs targeting sexually active homeless youths -- who are at particularly elevated risk for becoming infected with the human immunodeficiency virus (HIV) -- for early STD screening.

Contracting an STD can predispose one to becoming infected with the deadly virus that leads to acquired immunodeficiency syndrome (AIDS), said Dr. Rosa Solorio, assistant professor of family medicine at the David Geffen School of Medicine at UCLA and the study's lead researcher. Some of these infections do not present symptoms and these youths may not be aware of the need for testing, despite the high rates of STDs among them.

"We have to screen these youths to prevent a more negative outcome like HIV," Solorio said. "They need timely STD detection and treatment, and what the study shows is that the kids who are at highest risk are not getting tested."

The researchers surveyed 261 homeless youth who were aged 12 to 20, had been away from home at least two nights but less than six months and, if under age 17, were away from home without their parents' or guardians' permission or had been kicked out of the house. They were interviewed over 12 months between 2001 and 2002. The subjects were selected from 17 shelters and drop-in centers and 13 street hangout sites throughout Los Angeles County. Of those surveyed, half had been sexually active in the previous three months.

The researchers found
'"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
17-Feb-2006


Page: 1 2

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Adolescents with high-risk sexual attitudes attract peers with similar attitudes
3. Percutaneous aortic valve replacement safe, successful in high-risk patients
4. Rhode Island Hospital study identifies high-risk patient populations for MRSA carriage
5. Alcohol interventions that teach practical skills work best with high-risk university students
6. Alcohol and high-risk sexual behaviors in Botswana
7. Drug could prevent type 2 diabetes in high-risk individuals
8. New HIV study identifies high-risk subgroups of adolescents
9. Use of breast MRI can be cost-effective for some women at high-risk of breast cancer
10. Doctors able to predict recurrence of high-risk breast cancers
11. Mammography does not increase risk of breast cancer in high-risk women

Post Your Comments:
(Date:3/6/2015)... The Public Health Accreditation Board ... status to seven more health departments. This week’s decisions ... people can now be assured that their health departments ... of their communities. , Public health departments play a ... people and communities. Across the nation, health departments provide ...
(Date:3/5/2015)... global digital PCR (dPCR) and qPCR market is expected to reach ... 2019. , The global digital PCR (dPCR) and qPCR market is ... 2019. Although the mature markets such as the U.S., Germany, France ... qPCR market the Asia-Pacific region is expected to grow at the ... the digital PCR (dPCR) and qPCR market is driven by factors ...
(Date:3/5/2015)... 05, 2015 A Bakersfield, Calif. state court ... trial awarding the plaintiff Coleen M. Perry a total ... of a TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, ... Cartmell , a partner at Wagstaff & Cartmell ... the plaintiff, along with Rich Freese and Tim Goss of ...
(Date:3/5/2015)... New York (PRWEB) March 05, 2015 ... men who allegedly suffered heart attacks, strokes and other ... low testosterone therapies continue to move forward in the ... Northern District of Illinois. According to a Case Management ... forth procedures for the use of master pleadings in ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... this March with extra savings on their ... important of health and nutrition, HomeCEUConnection.com is ... using the promo code, NUTRITION2015 . ... Professionals , HomeCEUConnection.com provides high-quality continuing ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2
(Date:3/5/2015)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... chronic pain, today announced the appointment of several ... panel of experts will provide support for planning ... the company pipeline of novel investigational therapies to ... range of areas including opioid receptors, addiction, psychiatry, ...
(Date:3/5/2015)... -- LUNGevity Foundation, the nation,s leading lung cancer ... approval of Bristol Myers Squibb,s new immunotherapy drug ... another critical new treatment option to fight lung ... own immune system to fight cancerous cells. Importantly, ... with squamous cell lung cancer, a population for ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... the "Japan Pharma Outlook 2015: Year to Watch ... Initiatives" report to their offering. ... from April -2014 (Annexure 1) is a ... - whether generic or innovator. The most of the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
Cached News: